AU Patent

AU2005318126A1 — Indolidone derivatives for the treatment or prevention of fibrotic diseases

Assigned to Boehringer Ingelheim International GmbH · Expires 2006-06-29 · 20y expired

What this patent protects

Patent listed against nintedanib-esylate.

Drugs covered by this patent

nintedanib-esylate (NINTEDANIB ESYLATE)

Patent Metadata

Patent number: AU2005318126A1
Jurisdiction: AU
Classification: —
Expires: 2006-06-29
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim International GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.